bluebird bio confirms that Ayrmid, Ltd. has not delivered a binding offer or obtained necessary financing despite extensive engagement
1. Ayrmid Ltd. failed to submit a binding proposal to acquire bluebird bio. 2. bluebird bio reaffirms support for its transaction with Carlyle and SK Capital.